Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3 - PRIMULTI): An open-label, randomised controlled trial

The Lancet

Volumn 386, Issue 9994, 2015, Pages 665-671

  Engstrøm, Thomas ^a   Kelbæk, Henning ^a,c   Helqvist, Steffen ^a   Høfsten, Dan Eik ^a   Kløvgaard, Lene ^a   Holmvang, Lene ^a   Jørgensen, Erik ^a   Pedersen, Frants ^a   Saunamäki, Kari ^a   Clemmensen, Peter ^a   De Backer, Ole ^a   Ravkilde, Jan ^b   Tilsted, Hans Henrik ^b   Villadsen, Anton Boel ^b   Aarøe, Jens ^b   Jensen, Svend Eggert ^b   Raungaard, Bent ^b   Køber, Lars ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b AALBORG UNIVERSITY HOSPITAL   (Denmark)

^c ROSKILDE HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PRASUGREL; TICAGRELOR; FIBRINOLYTIC AGENT;

ADULT; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DENMARK; FEMALE; FOLLOW UP; FRACTIONAL FLOW RESERVE; HEART MUSCLE REVASCULARIZATION; HUMAN; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPEN STUDY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; UNIVERSITY HOSPITAL; CLINICAL TRIAL; CORONARY STENOSIS; MIDDLE AGED; MYOCARDIAL INFARCTION; PATHOPHYSIOLOGY; PHYSIOLOGY; POSTOPERATIVE COMPLICATIONS; PROCEDURES; REOPERATION; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CORONARY STENOSIS; FEMALE; FIBRINOLYTIC AGENTS; FRACTIONAL FLOW RESERVE, MYOCARDIAL; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE COMPLICATIONS; REOPERATION; TREATMENT OUTCOME;

EID: 84939466415     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(15)60648-1     Document Type: Article

References (28)

1. S Windecker, P Kolh, F Alfonso for the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) 2014 ESC/EACTS guidelines on myocardial revascularization Eur Heart J 35 2014 2541 2619
2. PT O'Gara, FG Kushna, DD Ascheim et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation 127 2013 529 555
3. H Kelbæk, CJ Terkelsen, S Helqvist et al. Randomized comparison of distal protection versus conventional treatment in primary percutaneous coronary intervention: the drug elution and distal protection in ST-elevation myocardial infarction (DEDICATION) trial J Am Coll Cardiol 51 2008 899 905
4. S Rasoul, JP Ottervanger, MJ de Boer on behalf of the Zwolle Myocardial Infarction Study Group Predictors of 30-day and 1-year mortality after primary percutaneous coronary intervention for ST-elevation myocardial infarction Coron Artery Dis 20 2009 415 421
5. M Toma, CE Buller, CM Westerhout et al. Non-culprit coronary artery percutaneous coronary intervention during acute ST-segment elevation myocardial infarction: insights from the APEX-AMI trial Eur Heart J 31 2010 1701 1707
6. A Halkin, M Singh, E Nikolsky et al. Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score J Am Coll Cardiol 45 2005 1397 1405
7. P Sorajja, BJ Gersh, DA Cox et al. Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction Eur Heart J 28 2007 1709 1716
8. DWM Muller, EJ Topol, SG Ellis, KN Sigmon, K Lee, RM Califf Multivessel coronary artery disease: a key predictor of short-term prognosis after reperfusion therapy for acute myocardial infarction Am Heart J 121 1991 1042 1049
9. MA Cavender, S Milford-Beland, MT Roe, ED Peterson, WS Weintraub, SV Rao Prevalence, predictors and in-hospital outcomes of non-infarct artery intervention during primary percutaneous coronary intervention from ST-segment elevation myocardial infarction Am J Cardiol 104 2009 507 513
10. S Bangalore, S Kumar, KL Poddar et al. Meta-analysis of multivessel coronary artery revascularization versus culprit-only revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease Am J Cardiol 107 2011 1300 1310
11. A Sehti, A Bahekar, R Bhuriya, S Singh, A Ahmed, S Khosla Complete versus culprit only revascularization in acute ST elevation myocardial infarction: a meta-analysis Cathet Cardiovasc Interv 77 2011 163 170
12. PJ Vlaar, KD Mahmoud, DR Holmes et al. Culprit vessel only versus multivessel and staged percutaneous coronary intervention for multivessel disease in patients presenting with ST-segment elevation myocardial infarction: a pairwise and network meta-analysis J Am Coll Cardiol 58 2011 692 703
13. KR Bainey, SR Mehta, T Lai, RC Welsh Complete vs culprit-only revascularization for patients with multivessel disease undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a systematic review and meta-analysis Am Heart J 167 2014 1 14 e2.
14. C Di Mario, M Sansa, F Airoldi et al. Single vs multivessel treatment during primary angioplasty: results of the multicentre randomised HEpacoat for cuLPrit or multivessel stenting for Acute Myocardial Infarction (HELP AMI) study Int J Cardiovasc 6 2004 128 133
15. L Politi, F Sgura, R Rossi et al. A randomised trial of target-vessel versus multi-vessel revascularisation in ST-elevation myocardial infarction: major adverse cardiac events during long-term follow-up Heart 96 2010 662 667
16. J-HE Dambrink, JP Debrauwere, AWJ van't Hof et al. Non-culprit lesions detected during primary PCI: treat invasively or follow the guidelines? EuroIntervention 5 2010 968 975
17. DS Wald, JK Morris, NJ Wald et al. Randomized trial of preventive angioplasty in myocardial infarction N Engl J Med 369 2013 1115 1123
18. DJ Kelly, GP McCann, D Blackman et al. Complete Versus culprit-Lesion only PRimary PCI Trial (CVLPRIT): a multicentre trial testing management strategies when multivessel disease is detected at the time of primary PCI: rationale and design EuroIntervention 8 2013 1190 1198
19. PA Tonino, B De Bruyne, NH Pijls et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention N Engl J Med 360 2009 213 224
20. DE Høfsten, H Kelbæk, S Helqvist for the DANAMI 3 Investigators The Third DANish Study of Optimal Acute Treatment of Patients with ST-segment Elevation Myocardial Infarction: Ischemic postconditioning or deferred stent implantation versus conventional primary angioplasty and complete revascularization versus treatment of culprit lesion only - rationale and design of the DANAMI 3 trial program Am Heart J 169 2015 613 621
21. K Thygesen, JS Alpert, AS Jaffe et al. Third universal definition of myocardial infarction J Am Coll Cardiol 60 2012 1581 1598
22. R Glaser, F Selzer, DP Faxon et al. Clinical progression of incidental, asymptomatic lesions discovered during culprit vessel coronary intervention Circulation 111 2005 143 149
23. J Lønborg, N Vejlstrup, H Kelbæk et al. Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction Eur Heart J 33 2012 1491 1499
24. EL Hannan, Z Samadashvili, G Walford et al. Culprit vessel percutaneous coronary intervention versus multivessel and staged percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel disease J Am Coll Interv 3 2010 22 31
25. R Kornowski, R Mehran, G Dangas et al. Prognostic impact of staged versus "one-time" multivessel percutaneous intervention in acute myocardial infarction: analysis from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial J Am Coll Cardiol 58 2011 704 711
26. JA Goldstein, D Demetriou, CL Grines, M Pica, M Shoukfeh, WW O'Neill Multiple complex coronary plaques in patients with acute myocardial infarction N Engl J Med 343 2000 915 922
27. B De Bruyne, WF Fearon, NHJ Pijls et al. Fractional flow reserve-guided PCI for stable coronary artery disease N Engl J Med 371 2014 1208 1217
28. A Ntalianis, JW Sels, G Davidavicius et al. Fractional flow reserve for the assessment of nonculprit coronary artery stenoses in patients with acute myocardial infarction JACC Cardiovasc Interv 3 2010 1274 1281